Skip to content

aPROMISE X

by Exini Diagnostics Ab

510(k) K220590

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK220590 Date29 Apr 2022ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
1 Mar 2022
FDA decision
29 Apr 2022 (Substantially Equivalent)
FDA review time
59 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K220590 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K220590 decided 29 Apr 2022 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
LLZ
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The aPROMISE X is a dual-energy X-ray absorptiometry (DEXA) system designed for measuring bone mineral density and body composition. It employs low-dose X-ray technology to assess skeletal health, particularly in the detection of osteoporosis and related metabolic conditions, while also providing quantitative analysis of lean mass, fat mass, and visceral fat.

This device is intended for use in clinical settings such as hospitals, research laboratories, and specialized diagnostic centers. Supplied as a reusable medical device, it requires proper calibration and maintenance to ensure accurate measurements. The aPROMISE X holds FDA 510(k) clearance under the Traditional pathway and is authorized under the Medical Device Regulation (MDR). It is classified under product code LLZ and falls under the Radiology advisory committee’s review scope.

Devices cleared under K220590

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K220590
UDI-DISize and differences
aPROMISE 02
Exini Diagnostics AB
702 / 0207350002337028 —On the market
PYLARIFY AI 02
Exini Diagnostics AB
602 / 0207350002336021 —No longer on the market

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Exini Diagnostics Ab

  • aPROMISE

    Class II
  • Pylclari Ai

    Class IIa
  • EXINI Bone

    Class IIa
  • aBSI

    Class IIa